Dynamic cardiomyoplasty for heart failure.
R. C. Chiu
Br. Heart J. 1995; 73: 1-3. doi:10.1136/hrt.73.1.1
[PDF]
[Request Permissions]
Cholesterol lowering does have a role in secondary prevention.
D. A. Wood
Br. Heart J. 1995; 73: 4-5. doi:10.1136/hrt.73.1.4
[PDF]
[Request Permissions]
Use of the implantable defibrillator.
S. C. Hammil and M. S. Stanton
Br. Heart J. 1995; 73: 6-7. doi:10.1136/hrt.73.1.6
[PDF]
[Request Permissions]
A New Year toast ... to the cardioprotective effects of alcohol.
M. J. Griffith
Br. Heart J. 1995; 73: 8-9. doi:10.1136/hrt.73.1.8
[PDF]
[Request Permissions]
Increased monocyte tissue factor expression in coronary disease.
E. W. Leatham, P. M. Bath, J. A. Tooze, and A. J. Camm
Br. Heart J. 1995; 73: 10-13. doi:10.1136/hrt.73.1.10
[Abstract]
[PDF]
[Request Permissions]
Inhibition of superoxide production in human neutrophils by combinations of heparin and thrombolytic agents.
K. Riesenberg, F. Schlaeffer, A. Katz, and R. Levy
Br. Heart J. 1995; 73: 14-19. doi:10.1136/hrt.73.1.14
[Abstract]
[PDF]
[Request Permissions]
Infections after cardioverter-defibrillator implantation: observations in 335 patients over 10 years.
H. J. Trappe, P. Pfitzner, H. Klein, and P. Wenzlaff
Br. Heart J. 1995; 73: 20-24. doi:10.1136/hrt.73.1.20
[Abstract]
[PDF]
[Request Permissions]
Vasoconstrictor peptides and cold intolerance in patients with stable angina pectoris.
P. A. Dodds, C. M. Bellamy, R. A. Muirhead, and R. A. Perry
Br. Heart J. 1995; 73: 25-31. doi:10.1136/hrt.73.1.25
[Abstract]
[PDF]
[Request Permissions]
QT dispersion and components of the QT interval in ischaemia and infarction.
P. D. Higham, S. S. Furniss, and R. W. Campbell
Br. Heart J. 1995; 73: 32-36. doi:10.1136/hrt.73.1.32
[Abstract]
[PDF]
[Request Permissions]
Increased dispersion of refractoriness in the absence of QT prolongation in patients with mitral valve prolapse and ventricular arrhythmias.
R. G. Tieleman, H. J. Crijns, A. C. Wiesfeld, J. Posma, H. P. Hamer, and K. I. Lie
Br. Heart J. 1995; 73: 37-40. doi:10.1136/hrt.73.1.37
[Abstract]
[PDF]
[Request Permissions]
Activation and inhibition of the endogenous opioid system in human heart failure.
K. G. Oldroyd, C. E. Gray, R. Carter, K. Harvey, W. Borland, G. Beastall, and S. M. Cobbe
Br. Heart J. 1995; 73: 41-48. doi:10.1136/hrt.73.1.41
[Abstract]
[PDF]
[Request Permissions]
Morphological, haemodynamic, and clinical variables as predictors for management of isolated ventricular septal defect.
F. van den Heuvel, T. Timmers, and J. Hess
Br. Heart J. 1995; 73: 49-52. doi:10.1136/hrt.73.1.49
[Abstract]
[PDF]
[Request Permissions]
Doppler reconstruction of left ventricular pressure from functional mitral regurgitation: potential importance of varying orifice geometry.
H. B. Xiao, X. Y. Jin, and D. G. Gibson
Br. Heart J. 1995; 73: 53-60. doi:10.1136/hrt.73.1.53
[Abstract]
[PDF]
[Request Permissions]
Impairment of diastolic function during short-term anthracycline chemotherapy.
Y. Cottin, C. Touzery, B. Coudert, A. Gilles, P. Walker, J. L. Massing, M. Toubeau, A. Riedinger-Berriolo, D. Caillot, and P. Louis
Br. Heart J. 1995; 73: 61-64. doi:10.1136/hrt.73.1.61
[Abstract]
[PDF]
[Request Permissions]
Continuous low dose inhaled nitric oxide for treatment of severe pulmonary hypertension after cardiac surgery in paediatric patients.
M. Beghetti, W. Habre, B. Friedli, and M. Berner
Br. Heart J. 1995; 73: 65-68. doi:10.1136/hrt.73.1.65
[Abstract]
[PDF]
[Request Permissions]
Positron emission tomography with oxygen-15 of stunned myocardium caused by coronary artery vasospasm after recovery.
D. Agostini, H. Iida, and A. Takahashi
Br. Heart J. 1995; 73: 69-72. doi:10.1136/hrt.73.1.69
[Abstract]
[PDF]
[Request Permissions]
Haemochromatosis presenting as congestive cardiac failure.
J. Porter, N. Cary, and P. Schofield
Br. Heart J. 1995; 73: 73-75. doi:10.1136/hrt.73.1.73
[Abstract]
[PDF]
[Request Permissions]
Electrophysiology in a district general hospital.
A. Prakash and P. M. Holt
Br. Heart J. 1995; 73: 76-81. doi:10.1136/hrt.73.1.76
[Abstract]
[PDF]
[Request Permissions]
Immediate and long-term clinical outcome of coronary angioplasty in patients aged 35 years or less.
M. J. Kofflard, P. P. de Jaegere, R. van Domburg, P. Ruygrok, M. van den Brand, P. W. Serruys, and P. J. de Feyter
Br. Heart J. 1995; 73: 82-86. doi:10.1136/hrt.73.1.82
[Abstract]
[PDF]
[Request Permissions]
Women and myocardial infarction: agism rather than sexism?
J. N. Adams, M. Jamieson, J. M. Rawles, R. J. Trent, and K. P. Jennings
Br. Heart J. 1995; 73: 87-91. doi:10.1136/hrt.73.1.87
[Abstract]
[PDF]
[Request Permissions]
Determinants of the length of stay in intensive care and in hospital after coronary artery surgery.
J. P. Mounsey, M. J. Griffith, D. W. Heaviside, A. H. Brown, and D. S. Reid
Br. Heart J. 1995; 73: 92-98. doi:10.1136/hrt.73.1.92
[Abstract]
[PDF]
[Request Permissions]
Endotracheal tolazoline for severe persistent pulmonary hypertension of the newborn.
J. C. Welch, J. M. Bridson, and J. L. Gibbs
Br. Heart J. 1995; 73: 99-100. doi:10.1136/hrt.73.1.99
[Abstract]
[PDF]
[Request Permissions]